Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis. (Record no. 27356827)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02043 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517163211.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201901s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1473-1150 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/tpj.2017.31 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Loft, N D |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190111 |
| 245 00 - TITLE STATEMENT | |
| Title | Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The pharmacogenomics journal |
| Date of publication, distribution, etc. | 05 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 494-500 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adalimumab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Denmark |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Etanercept |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infliximab |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Interleukin-1beta |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphocyte Antigen 96 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Membrane Glycoproteins |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacogenetics |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polymorphism, Single Nucleotide |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psoriasis |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, Interleukin-1 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Toll-Like Receptor 2 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Toll-Like Receptor 9 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Necrosis Factor-alpha |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ustekinumab |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Skov, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iversen, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gniadecki, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dam, T N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brandslund, I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoffmann, H J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andersen, M R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dessau, R B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bergmann, A C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andersen, N M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andersen, P S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bank, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vogel, U |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Andersen, V |
| 773 0# - HOST ITEM ENTRY | |
| Title | The pharmacogenomics journal |
| Related parts | vol. 18 |
| -- | no. 3 |
| -- | p. 494-500 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/tpj.2017.31">https://doi.org/10.1038/tpj.2017.31</a> |
| Public note | Available from publisher's website |
No items available.